HOME >> BIOLOGY >> NEWS
VCU Massey Cancer Center researchers find new agent inhibits Leukemia cell survival

A team of researchers at Virginia Commonwealth University Massey Cancer Center has discovered an entirely new mechanism of action for a novel pharmacological agent currently in clinical trials in patients the kinase inhibitor BAY 43-9006 which was designed to disrupt the survival pathways of tumor cells.

"This agent was originally designed to inhibit the Raf-1 pathway, which is frequently mutated in many types of cancers, including leukemia," said Steven Grant, M.D., Massey's principal investigator for the study that was published in the Oct. 21 issue of the Journal of Biological Chemistry. BAY 43-9006 is a new agent known to induce apoptosis, or cell death, in a variety of tumor cells, presumably by interrupting this pathway. The agent was made available to Massey's researchers by the National Cancer Institute.

"We were surprised to find that the killing effects of Bay 43-9006 in human leukemia cells had very little to do with inhibition of the Raf-1 pathway," Grant said. "Instead, the major mechanism of lethality of this compound involved down-regulation of a protein known as Mcl-1, which plays a critical role in protecting leukemic cells from apoptosis.

"What was even more interesting was that Bay 43-9006 appeared to reduce Mcl-1 levels by an unusual and unexpected mechanism-inhibition of the initiation of protein synthesis," Grant said. "This insight into the mode of action of Bay 43-9006 could have important implications for the development of rational combination strategies involving this agent in leukemia and potentially other types of cancer."

Grant is Massey's associate director for translational research and co-leader of the cancer center's cell-signaling program. He provides national leadership in hematologic malignancy research focused on finding new treatments for blood cancers such as leukemias, lymphomas and multiple myeloma. His work is funded by the National Cancer Institute, the V Foundation for Cancer Researc
'"/>

Contact: Andrea Butler
albutler@vcu.edu
804-628-2111
Virginia Commonwealth University
21-Oct-2005


Page: 1 2

Related biology news :

1. Massey researchers induce cell death in leukemia
2. VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum
3. VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells
4. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
5. Journalists can register now for ECCO 14 -- the European Cancer Conference
6. Cancer cures could work for canines and humans
7. The Cancer Genome Atlas awards funds for technology development
8. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
9. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
10. Cancer stem cells can go it alone
11. Cancer drug enhances long-term memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... In its ... feature interview with Dr. James L. Sherley, M.D., Ph.D., founder and director of ... the company announced on June 16 that starting July 5 it would ...
(Date:6/11/2020)... ... June 08, 2020 , ... ... and other protective measures to protect workers in the medical field. The face ... staffs who valiantly risk their lives every day to provide healthcare to pregnant ...
(Date:6/2/2020)... MILWAUKEE (PRWEB) , ... June ... ... International, the world’s leading barcode and RFID labeling software developer and solutions ... TEKLYNX CENTRAL , improved labeling accuracy and compliance by 100%, resulting ...
Breaking Biology News(10 mins):
(Date:6/3/2020)... MONTREAL (PRWEB) , ... June 03, 2020 , ... ... designed to highlight various applications of biofeedback. In the next installment, Dr. Inna ... a practice whereby individuals learn to bring their attention to the feelings, thoughts, ...
(Date:5/30/2020)... ... 29, 2020 , ... Medrio, Inc., the leading provider of ... enabled Cytovale, Inc., a medical technology company dedicated to revolutionizing diagnostics for conditions ... patient in (FPI) in just seven days. The Cytovale technology will allow patients ...
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... ... R&D, today announced the release of Genedata Screener ® 17.0, the latest ... screening data from all in-vitro screening assay technologies. Genedata will host a webinar ...
(Date:5/26/2020)... ... May 26, 2020 , ... Brilliant , the leading smart ... smart garage door openers, announce a new integration to bring more convenience, simplicity, and ... openers powered by Aladdin Connect® can now be controlled from Brilliant’s in-wall touchscreen control ...
Breaking Biology Technology:
Cached News: